Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioFCF Payout RatioInventory AverageInvested Capital

Conmed (CNMD) EBIT Margin (2016 - 2020)

Historic EBIT Margin for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to 53.6%.

  • Conmed's EBIT Margin changed 0.0% to 53.6% in Q4 2020 from the same period last year, while for Dec 2020 it was 53.37%, marking a year-over-year decrease of 15700.0%. This contributed to the annual value of 7.46% for FY2025, which is 78600.0% down from last year.
  • According to the latest figures from Q4 2020, Conmed's EBIT Margin is 53.6%, which was down 0.0% from 56.21% recorded in Q3 2020.
  • In the past 5 years, Conmed's EBIT Margin registered a high of 56.21% during Q3 2020, and its lowest value of 45.59% during Q2 2020.
  • In the last 5 years, Conmed's EBIT Margin had a median value of 54.43% in 2018 and averaged 53.98%.
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 32900bps in 2017, then tumbled by -94700bps in 2020.
  • Conmed's EBIT Margin (Quarter) stood at 52.41% in 2016, then increased by 6bps to 55.7% in 2017, then dropped by -2bps to 54.72% in 2018, then decreased by -2bps to 53.6% in 2019, then fell by 0bps to 53.6% in 2020.
  • Its EBIT Margin was 53.6% in Q4 2020, compared to 56.21% in Q3 2020 and 45.59% in Q2 2020.